Phio Pharmaceuticals Corp. (PHIO)
1.15
-0.03
(-2.54%)
USD |
NASDAQ |
Aug 24, 16:00
1.15
0.00 (0.00%)
After-Hours: 20:00
Phio Pharmaceuticals Shareholders Equity (Quarterly) : 12.60M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 12.60M |
| March 31, 2026 | 16.46M |
| December 31, 2025 | 20.15M |
| September 30, 2025 | 9.839M |
| June 30, 2025 | 10.10M |
| March 31, 2025 | 12.17M |
| December 31, 2024 | 4.723M |
| September 30, 2024 | 4.946M |
| June 30, 2024 | 3.773M |
| March 31, 2024 | 5.604M |
| December 31, 2023 | 7.73M |
| September 30, 2023 | 7.213M |
| June 30, 2023 | 9.904M |
| March 31, 2023 | 7.311M |
| December 31, 2022 | 10.84M |
| September 30, 2022 | 13.53M |
| June 30, 2022 | 17.00M |
| March 31, 2022 | 19.45M |
| December 31, 2021 | 21.93M |
| September 30, 2021 | 25.25M |
| June 30, 2021 | 28.84M |
| March 31, 2021 | 31.40M |
| December 31, 2020 | 13.02M |
| September 30, 2020 | 15.45M |
| June 30, 2020 | 17.73M |
| Date | Value |
|---|---|
| March 31, 2020 | 11.98M |
| December 31, 2019 | 5.748M |
| September 30, 2019 | 7.605M |
| June 30, 2019 | 9.707M |
| March 31, 2019 | 11.66M |
| December 31, 2018 | 13.58M |
| September 30, 2018 | 1.75M |
| June 30, 2018 | 3.272M |
| March 31, 2018 | 0.567M |
| December 31, 2017 | 1.833M |
| September 30, 2017 | 3.43M |
| June 30, 2017 | 5.937M |
| March 31, 2017 | 8.247M |
| December 31, 2016 | 10.86M |
| September 30, 2016 | 3.036M |
| June 30, 2016 | 4.968M |
| March 31, 2016 | 6.953M |
| December 31, 2015 | 8.89M |
| September 30, 2015 | 11.03M |
| June 30, 2015 | 13.13M |
| March 31, 2015 | 5.613M |
| December 31, 2014 | 7.855M |
| September 30, 2014 | 9.745M |
| June 30, 2014 | 11.50M |
| March 31, 2014 | 11.07M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Imunon, Inc. | 4.189M |
| Agenus, Inc. | -199.08M |
| Amgen, Inc. | 11.69B |
| Anika Therapeutics, Inc. | 137.28M |
| BioCryst Pharmaceuticals, Inc. | -454.29M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 14.31M |
| Total Liabilities (Quarterly) | 1.705M |
| Current Ratio | 8.386 |